LEETREXATE 7.5 MG contains Methotrexate 7.5 mg, a medicine with immunosuppressive and anti-inflammatory properties used for specific medical conditions. It may be prescribed for rheumatoid arthritis, psoriasis, psoriatic arthritis, and certain other autoimmune or inflammatory disorders under specialist supervision. Methotrexate works by interfering with folate-dependent processes and reducing excessive immune-system activity. LEETREXATE 7.5 MG is generally used according to a carefully planned dosing schedule, and for many inflammatory conditions methotrexate is prescribed once weekly rather than daily. The exact dose and duration should always be determined by a qualified healthcare professional. Regular monitoring of blood counts, liver function, and kidney function may be required during treatment. Patients should discuss pregnancy, breastfeeding, liver or kidney disease, infections, and other medicines with their doctor before starting therapy. Possible side effects include nausea, mouth sores, fatigue, abdominal discomfort, and changes in blood-cell counts. Methotrexate can cause serious toxicity if taken incorrectly, so patients should follow the prescribed schedule precisely and seek medical advice for concerning symptoms. LEETREXATE 7.5 MG is available for pharmaceutical export requirements through Phoenix Exim, India, for eligible international buyers and distributors.
CONTACT PHOENIX EXIM
Contact No. / WhatsApp: +91-9307610860 & +91-9860818372
Email: phoenixexim2000@gmail.com
